MedTrace Logo

Low Dose Aspirin Alerts in High-Risk Pregnancies

NCT05802940 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 839

Last updated 2025-12-17

No results posted yet for this study

Summary

The goal of this study is to assess the effect of an electronic health record (EHR) clinical decision support tool, also known as a best practice alert (BPA), on healthcare provider recommendations for low dose aspirin use in a high-risk pregnant patient population. The investigators hypothesize that the implementation of the EHR BPA tool will increase the healthcare provider's recommendation for low dose aspirin compared to current standard care.

Conditions

  • Preeclampsia
  • Aspirin
  • Clinical Decision Support Systems
  • Economics, Behavioral

Interventions

BEHAVIORAL

Electronic health record best practice alert

The electronic health record will identify patients at high-risk for preeclampsia and candidate for low dose aspirin (LDA) prophylaxis. For those in the intervention group, a best practice alert will notify the healthcare provider within the patient's chart during a prenatal visit that LDA should be recommended.

Sponsors & Collaborators

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • A. Dhanya Mackeen, MD, MPH · Geisinger Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-19
Primary Completion
2025-10-09
Completion
2026-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05802940 on ClinicalTrials.gov